Clinical trials
Recruiting Leukemia, Lymphocytic, Chronic, B-Cell trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BeOne Medicines | 4 |
| Loxo Oncology, Inc. | 2 |
| Merck Sharp & Dohme LLC | 2 |
| AstraZeneca | 1 |
| British Columbia Cancer Agency | 1 |
| CSL Behring | 1 |
| Canadian Cancer Trials Group | 1 |
| Eli Lilly and Company | 1 |
| National Cancer Institute (NCI) | 1 |
| Ottawa Hospital Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Lymphocytic, Chronic, B-Cell | 16 |
| Lymphoma, Mantle-Cell | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Leukemia, B-Cell | 2 |
| Lymphoma, B-Cell, Marginal Zone | 2 |
| Lymphoma, Follicular | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Multiple Myeloma | 2 |
| Recurrence | 2 |
| Waldenstrom Macroglobulinemia | 2 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.